Abstract
Background
Colorectal cancer (CRC) rarely metastasizes to the brain. The incidence of cerebral metastases (CM) is estimated between 1 and 3%. Given the improved survival from advanced CRC as a result of surgical and oncological advances, it is anticipated that the incidence of patients with CM from CRC will rise over the next few years. The aim of this article was to systematically review the treatment options and outcome of patients with CM from CRC.
Methods
PubMed and Medline databases were examined using the search words or MESH headings “colorectal” “cancer/carcinoma/adenocarcinoma”, “cerebral”/”brain” and “metastases/metastasis”.
Results
CM from CRC are diagnosed on average 28.3 months after the primary tumour. The median survival time following diagnosis is 5.3 months. Surgery (with or without associated radiotherapy), stereotactic radiosurgery, whole brain radiotherapy and best supportive care result in median survival of 10.3, 6.4, 4.4 and 1.8 months, respectively. On average, the 1-year overall survival rate for patients with CM from CRC regardless of the treatment modality is estimated to be around 24%.
Conclusions
The prognosis of patients with CM from CRC is dismal. Surgery may increase survival, but the additional benefit of perioperative radiotherapy cannot be ascertained due to paucity of data. Further studies are required to identify the role of the different oncological and surgical therapies and identify those patients likely to benefit most. Identification of patients who are at higher risk of developing brain metastases may be another important area for future research.
Similar content being viewed by others
References
Tokoro T, Okuno K, Hida JC et al (2014) Prognostic factors for patients with advanced colorectal cancer and symptomatic brain metastases. Clin Colorectal Cancer 4(13):226–231
Suzuki Y, Yamaguchi T, Matsumoto H et al (2014) Prognostic factors and treatment effects in patients with curatively resected brain metastasis from colorectal cancer. Dis Colon Rectum 1(57):56–63
Fokas E, Henzel M, Hamm K, Surber G, Kleinert G, Engenhart-Cabillic R (2011) Multidisciplinary Treatment of brain metastases derived from colorectal cancer incorporating stereotactic radiosurgery: analysis of 78 patients. Clin Colorectal Cancer 2(10):121–125
Jung M, Ahn JB, Chang JH et al (2011) Brain metastases from colorectal carcinoma: prognostic factors and outcomes. J Neurooncol 101:49–55
Schoeggl A, Kitz K, Reddy M, Zauner C (2002) Stereotactic radiosurgery for brain metastases from colorectal cancer. Int J Colorectal Dis 17:150–155
Wronski M, Arbit E (1999) Resection of brain metastases from colorectal carcinoma in 73 patients. Cancer 8(85):1677–1685
Alden T, Gianino J, Seclarides T (1996) Brain metastases from colorectal cancer. Dis Colon Rectum 5(39):541–545
Magni E, Santoro L, Ravenda PS et al (2014) Brain metastases from colorectal cancer: main clinical factors conditioning outcome. Int J Colorectal Dis 29:201–208
Kim HJ, Huh JW, Jung TY et al (2013) Clinical outcome with gamma-knife surgery or surgery for brain metastases from colorectal cancer. J Clin Neurosci 20:1417–1421
Kye B, Kim H, Kang W, Cho H, Hong Y, Oh S (2012) Brain metastases from colorectal cancer: the role of surgical resection in selected patients. Colorectal Dis 14:378–385
Matsunga S, Shuto T, Kawahara N, Suenaga J, Inomori S, Fujino H (2011) Gamma knife surgery for brain metastases from colorectal cancer. J Neurosurg 114:782–789
Aprile G, Zanon E, Tuniz F et al (2009) Neurosurgical management and postoperative whole-brain radiotherapy for colorectal cancer patients with symptomatic brain metastases. J Cancer Res Clin Oncol 135:451–457
Hammoud M, McCutcheon I, Elsouki R, Schoppa D, Patt Y (1995) Colorectal carcinoma and brain metastasis: distribution, treatment and survival. Ann Surg Oncol 5(3):453–463
Byrne B, Geddes T, Welsh F, John T, Chandrakumaran K, Rees M (2011) The incidence and outcome of brain metastases after liver resection for colorectal cancer metastases. Colorectal Dis 14:721–726
Mege D, Ouaissi M, Fuks D et al (2013) Patients with brain metastases from colorectal cancer are not condemned. Anticancer Res 33:5645–5648
Noura S, Ohue M, Shingai T et al (2012) Brain metastasis from colorectal cancer: prognostic factors and survival. J Surg Oncol 106:144–148
Jiang X, Yang Q, Sai K, Zhang X, Chen Z, Mou Y (2011) Brain metastases from colorectal carcinoma: a description of 60 cases in a single Chinese cancer center. Tumour Biol 32:1249–1256
Amichetti M, Lay G, Dessi M et al (2005) Results of whole brain radiation therapy in patients with brain metastases from colorectal carcinoma. Tumori 91:161–167
Baek JY, Kang MH, Hong YS et al (2011) Characteristics and prognosis of patients with colorectal cancer associated brain metastases in the era of modern systemic chemotherapy. J Neurooncol 104:745–753
D’Andrea G, Isidori A, Caroli E, Orlando E, Salvati M (2004) Single cerebral metastasis from colorectal adenocarcinoma. Neurosurg Rev 27:55–57
Gu X, Cai Y, Zhou Y, Li Z, Xiang J, Chen Z (2015) Prognostic factors and multidisciplinary treatment modalities for brain metatases from colorectal cancer: analysis of 93 patients. BMC Cancer 15:902
Zorrilla M, Alonso V, Herrero A et al (2001) Brain metastases from colorectal carcinoma. Tumori 87:332–334
Farnell G, Buckner J, Cascino T, O’Connell M, Schomberg P, Suman V (1996) Brain metastases from colorectal carcinoma: the long term survivors. Cancer 4(78):711–717
Yaeger R, Cowell E, Chou JF et al (2015) RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer. Cancer 15:1195–1203
Lipsyc M, Yaeher R (2015) Impact of somatic mutations on patterns of metastasis in colorectal cancer. J Gastrointest Oncol 6(6):645–649
Authors’ contribution
All authors contributed to the literature review and the preparation of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The review has been conducted according to accepted principles of ethical and professional conduct.
Informed consent
For this type of study formal consent not required.
Rights and permissions
About this article
Cite this article
Silva, I.L., Iskandarani, M., Hotouras, A. et al. A systematic review to assess the management of patients with cerebral metastases secondary to colorectal cancer. Tech Coloproctol 21, 847–852 (2017). https://doi.org/10.1007/s10151-017-1707-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10151-017-1707-8